Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.
暂无分享,去创建一个
Kim-Anh Do | Wadih Arap | Renata Pasqualini | Johanna Lahdenranta | M. Ozawa | D. Scudiero | E. Sausville | K. Do | W. Arap | S. Holbeck | M. Cardó-Vila | R. Pasqualini | F. I. Staquicini | M. Kolonin | A. Zurita | L. Bover | G. Souza | D. Jaalouk | J. Lahdenranta | Glauco R Souza | Jessica Sun | Mikhail G Kolonin | Marina Cardó-Vila | Susan L Holbeck | Edward A Sausville | Jessica H Sun | Laura Bover | R. Giordano | C. Moya | Akihiko Kunyiasu | Michael G Ozawa | Ricardo J Giordano | Dominic A Scudiero | Amado J Zurita | Diana E Jaalouk | Catherine A Moya | Fernanda I Staquicini | Akihiko Kunyiasu | Catherine A. Moya
[1] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[2] R Pasqualini,et al. Molecular addresses in blood vessels as targets for therapy. , 2001, Current opinion in chemical biology.
[3] P. Troncoso,et al. Combinatorial Screenings in Patients , 2004, Cancer Research.
[4] Anders Wallqvist,et al. Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data , 2003, Bioinform..
[5] John N Weinstein,et al. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. , 2004, Cancer cell.
[6] D. Scudiero,et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.
[7] J. Brown,et al. NCI's anticancer drug screening program may not be selecting for clinically active compounds. , 1997, Oncology research.
[8] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[9] E. Sausville,et al. Mining the National Cancer Institute's tumor-screening database: identification of compounds with similar cellular activities. , 2002, Journal of medicinal chemistry.
[10] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[11] J N Weinstein,et al. A protein expression database for the molecular pharmacology of cancer , 1997, Electrophoresis.
[12] Anders Wallqvist,et al. Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology. , 2002, Molecular cancer therapeutics.
[13] S. Holbeck,et al. Update on NCI in vitro drug screen utilities. , 2004, European journal of cancer.
[14] W. Arap,et al. Teratogenicity induced by targeting a placental immunoglobulin transporter , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] Wadih Arap,et al. Biopanning and rapid analysis of selective interactive ligands , 2001, Nature Medicine.
[16] Wadih Arap,et al. Reversal of obesity by targeted ablation of adipose tissue , 2004, Nature Medicine.
[17] Erkki Ruoslahti,et al. Organ targeting In vivo using phage display peptide libraries , 1996, Nature.
[18] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[19] D. Zaharevitz,et al. COMPARE: a web accessible tool for investigating mechanisms of cell growth inhibition. , 2002, Journal of molecular graphics & modelling.
[20] Carlos F. Barbas,et al. Phage display: a Laboratory manual , 2014 .
[21] William C Reinhold,et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Kim-Anh Do,et al. Steps toward mapping the human vasculature by phage display , 2002, Nature Medicine.
[23] J. Weinstein,et al. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data , 2002, The Pharmacogenomics Journal.
[24] R Pasqualini,et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. , 2000, Cancer research.